| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Head Of Development &CMO | Chief Medical Officer
3 companies
Agarwal Sunil is an EVP, Head Of Development &CMO at Sana Biotechnology, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $6.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | SANA Sana Biotechnology, Inc. | EVP, Head Of Development &CMO | Sell | 60,000 | $26.07 | $1,564,056.92 | -1.9% | -33.8% | -74.6% | |
| Jul 21, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 649 | $52.68 | $34,189.32 | -6.4% | - | - | |
| Jun 20, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 650 | $54.16 | $35,204.00 | -5.8% | - | - | |
| May 24, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 650 | $66.00 | $42,900.00 | -8.4% | - | - | |
| Apr 20, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 649 | $70.53 | $45,773.97 | -7.0% | - | - | |
| Mar 22, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 650 | $61.45 | $39,942.50 | -6.3% | - | - | |
| Feb 22, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 658 | $63.48 | $41,769.84 | -5.8% | - | - | |
| Jan 20, 2016 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 585 | $72.83 | $42,605.55 | -4.6% | - | - | |
| Dec 22, 2015 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 498 | $114.81 | $57,175.38 | -3.6% | - | - | |
| Nov 23, 2015 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 498 | $95.88 | $47,748.24 | -3.5% | - | - |